Trial Library just secured a fresh $10M Series A, and it feels like someone finally turned the lights on in the clinical trial maze. For years, access to oncology research has been a VIP room with a bouncer who somehow never lets the people who actually need the treatment inside. Dr. Hala Borno built this company after a decade of studying those inequities at UCSF and seeing the real stories behind the numbers. When your clinical experience keeps showing you the same locked doors, eventually you stop knocking and build your own building. Bringing in Co-Founder Steve Buck, a health tech operator who has been in the trenches long before AI was a pitch deck accessory, gave the company the kind of entrepreneurial muscle that makes the mission scalable instead of sentimental.
There is something fitting about calling it Trial Library. For years, trials have been treated like rare books that only a few institutions could access. Now providers across 320+ clinics and over 1,500 clinicians can get curated trial matches in under 30 secs. That is not wishful innovation. That is engineering built for real life, the kind of practicality you only get when your research starts with community oncologists instead of conference halls. When 85% of cancer patients receive care in community settings, it becomes obvious where the infrastructure needed to evolve. Trial Library simply chose to build where the patients already are.
This round, co-led by SemperVirens Venture Capital and NEXT Ventures with participation from Sanofi Ventures, Lux Capital, Civilization Ventures, Overwater Ventures, and How Women Invest, looks like a group that did their homework. You do not back a company like this unless you understand that oncology access is not a theoretical problem. It is a logistical one. And while most platforms stop at matching, this team went further by lining up incentives across patients, providers, payers, and biopharma in a way that finally makes the economics make sense. Their partnerships with Johnson & Johnson and Sanofi, plus being the first platform to unlock the payer market for trial access, show exactly why investors leaned in.
CPO Karim Damji brings two decades of digital health experience that turns vision into blueprints, and with Dr. Craig L. Tendler advising on clinical and scientific direction, the company has the kind of depth that cannot be manufactured. With the new capital, Trial Library is expanding nationally, accelerating payer and life science collaborations, and hiring across engineering, product, operations, sales, and finance. For every clinic that felt like clinical trials were kept somewhere out of reach, this moment signals a future where access is no longer a luxury but an expectation. The market is shifting, and Trial Library is writing the next chapter one patient at a time.
Startups Startup Funding Venture Capital Series A AI Research Digital Health Healthcare Health Tech Infrastructure Technology Innovation Tech Ecosystem Startup Ecosystem Hiring Tech Hiring
